Glucose News and Research

RSS

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Dengue is a mosquito-borne tropical disease currently endemic in more than 10 countries. According to the World Health Organization, 390 million people are infected by dengue every year.

7 Oct 2015

Cardiovascular disease risk can now be predicted for teens

Risk for cardiovascular disease, currently running rampant in the United States, can now be predicted for adolescents thanks to a new diagnostic test developed by a University of Virginia Children's Hospital pediatrician and his collaborators. The test accounts for many risk factors for the deadly disease and has the potential to be adapted by physicians nationwide to assess teenagers' future risk and encourage the healthy behaviors that could save their lives.

7 Oct 2015

Insulin sensitivity of main glucose storage sites in the body improve following gastric bypass surgery

Roux-en-Y, the most common type of gastric bypass surgery, can lead to remission of type 2 diabetes along with weight loss. A new study in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology examines why, finding that insulin sensitivity of the main glucose (sugar) storage sites in the body improve after gastric bypass surgery.

5 Oct 2015

U.S 2nd Annual Obesity Summit: 35 major U.S. health societies see how they can treat obesity

Representatives from 35 major health and medical organizations including, the American Diabetes Association (ADA), American Medical Association (AMA), American Heart Association (AHA), American Academy of Orthopaedic Surgeons (AAOS), and American Society of Clinical Oncology (ASCO) convened for a second annual summit in Chicago to identify opportunities for collaboration in treating obesity. “The National Obesity Summit on the Provision of Care for the Obese Patient” was hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS).

4 Oct 2015

One-third of people living with diabetes fail to report night-time hypoglycaemia to their doctor, shows research

A new survey reports that one-third (32%) of people living with diabetes failed to report night-time hypoglycaemia to their doctor or nurse despite the impact they have on the lives of people living with the condition.

1 Oct 2015

Novel portable device counts white blood cells in real time

A novel way to count white blood cells without a blood test, simply by applying a small device on the fingertip, is being developed by a team of young bioengineers. The technology, that combines an optical sensor with algorithms, has already three prototypes on the go and is specially designed to be used on chemotherapy patients, who could know their immune system levels in real time. It could also serve to detect serious infections.

30 Sep 2015

New study identifies inflammatory lung disease as risk factor for insulin resistance, diabetes

Numerous studies have identified obesity and poor diet as risk factors for insulin resistance and diabetes. A new study adds another risk factor to the list: inflammatory lung disease. Published in the American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, the study reports that inflammation in the lungs is enough to induce the body-wide inflammation that can lead to insulin resistance.

30 Sep 2015

Risks of developing type 2 diabetes for South Asians begin immediately at birth

New research suggests that the risks of developing type 2 diabetes for South Asians - a group long known to suffer from substantially higher rates of both diabetes and heart disease—begins immediately at birth.

30 Sep 2015

Light-shielded delivery system for parenteral nutrition may improve survival rate of preemies

The survival rate of preemies born between 26 to 31 weeks of gestation is improved by blocking light from reaching the intravenously-fed infused nutritious mixture they depend on for survival, researchers at CHU Sainte-Justine and the University of Montreal have revealed in a new study.

28 Sep 2015

Researchers identify new biochemical pathway that could be a potential target for insulin control

In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.

25 Sep 2015

Medication used for diabetes could be a valuable tool for treating alcohol dependence

A new study on mice and rats at Sahlgrenska Academy shows that a medication used for diabetes and obesity also could be a valuable tool for the treatment of alcohol dependence.

25 Sep 2015

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

EKF, announces the UK launch of the Altair™ 240 clinical chemistry analyser at the Institute of Biomedical Science Congress 2015 in Birmingham.

From EKF Diagnostics 24 Sep 2015

Researchers extend innovative research towards a cure for type I diabetes

Associate Professor Shane Grey, of Sydney's Garvan Institute of Medical Research, together with collaborators from the Westmead Millennium Institute for Medical Research and the Children's Hospital at Westmead, have been awarded $3.3 million to extend their innovative research towards a cure for type I diabetes.

23 Sep 2015

Fidgeting movements may counteract adverse health impacts of sitting for long periods

New research suggests that the movements involved in fidgeting may counteract the adverse health impacts of sitting for long periods.

23 Sep 2015

University of Adelaide study sheds light on the activity of cancer-suppressing gene

University of Adelaide researchers have uncovered the role played by a gene which suppresses the development of cancer. The findings, published in the journal PLOS ONE, open new opportunities for scientists to find treatments for cancer.

23 Sep 2015

Researchers identify a protein that could potentially stop cancer

Scientists know that most cancer cells use glucose to fuel their uncontrolled growth and now an international team of researchers has identified a protein which if switched off could stop the disease in its tracks.

22 Sep 2015

Discovery may lead to potential treatment strategies for type 2 diabetes

Insensitivity to insulin, also called insulin resistance, is associated with type 2 diabetes and affects several cell types and organs in the body. Now, scientists from Sweden's Karolinska Institutet have discovered a mechanism that explains how insulin-producing cells can be insulin resistant and insulin sensitive at the same time.

18 Sep 2015

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

Myc is a cancer-causing gene responsible for disrupting the normal 24-hour internal rhythm and metabolic pathways in cancer cells, found a team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Postdoctoral fellow Brian Altman, PhD, and doctoral student Annie Hsieh, MD, both from the lab of senior author Chi Van Dang, MD, PhD, director Abramson Cancer Center, study body clock proteins associated with cancer cells.

18 Sep 2015

O'Neal Industries, McKesson win 2015 C. Everett Koop National Health Awards

About half of companies with 50 or more employees report that they have at least one health promotion program in place. For large companies, this jumps to over 90 percent. However, not all wellness programs can document health improvements for their employees and cost savings. To make sure that workplace health promotion programs apply evidence-based practices and significantly reduce expenditures, companies must adopt high-impact programs and periodically evaluate their results.

16 Sep 2015

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).

16 Sep 2015

Glucose News and Research

NS1 protein can be considered as vital target for development of new drugs to treat dengue: Study

Cardiovascular disease risk can now be predicted for teens

Insulin sensitivity of main glucose storage sites in the body improve following gastric bypass surgery

U.S 2nd Annual Obesity Summit: 35 major U.S. health societies see how they can treat obesity

One-third of people living with diabetes fail to report night-time hypoglycaemia to their doctor, shows research

Novel portable device counts white blood cells in real time

New study identifies inflammatory lung disease as risk factor for insulin resistance, diabetes

Risks of developing type 2 diabetes for South Asians begin immediately at birth

Light-shielded delivery system for parenteral nutrition may improve survival rate of preemies

Researchers identify new biochemical pathway that could be a potential target for insulin control

Medication used for diabetes could be a valuable tool for treating alcohol dependence

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

Researchers extend innovative research towards a cure for type I diabetes

Fidgeting movements may counteract adverse health impacts of sitting for long periods

University of Adelaide study sheds light on the activity of cancer-suppressing gene

Researchers identify a protein that could potentially stop cancer

Discovery may lead to potential treatment strategies for type 2 diabetes

Cancer-causing gene disrupts internal rhythm, metabolic pathways in cancer cells

O'Neal Industries, McKesson win 2015 C. Everett Koop National Health Awards

AstraZeneca presents safety and efficacy data for ExQW at 51st Annual Meeting of EASD

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News